Effect of Vitamin E and Pioglitazone in patients with non-alcoholic fatty liver disease
Not Applicable
- Conditions
- on-alcoholic fatty liver.Nonalcoholic steatohepatitis
- Registration Number
- IRCT201705016312N4
- Lead Sponsor
- Vice chancellor for research, Shiraz University Of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Inclusion Criteria: Patients with NAFLD confirmed by performing liver sonography and increased levels of liver enzymes AST and ALT.
Exclusion Criteria
History of alcohol consumption; diabetes; chronic liver disease; use of drugs such as statin, fibrate.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver function test. Timepoint: Before intervention - 3 months after intervention. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method Body Mass Index. Timepoint: Before intervention - 3 months after intervention. Method of measurement: By BMI Formula.